- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04243369
Collaboration Live
November 10, 2020 updated by: Philips Clinical & Medical Affairs Global
Collaboration Live Clinical Study
Collaboration Live is a prospective, single-arm clinical study of subjects who provide written consent.
Subjects are scanned using a Philips EPIQ 5 or EPIQ 7 Ultrasound System equipped with Collaboration Live software.
The study investigator will evaluate performance of the Collaboration Live tool with regard to performance of conferencing, sharing and control capabilities.
Adverse events will be reported and the study investigator will assess potential relationship to the study device or study procedure.
Additionally, the utility of Collaboration Live in remote consult of study patients will be evaluated.
No patient follow-up beyond the initial consultation will be conducted with the Collaboration Live software solution.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87106
- Perinatal Associates of New Mexico
-
Rio Rancho, New Mexico, United States, 87124
- Perinatal Associates of New Mexico
-
Santa Fe, New Mexico, United States, 87505
- Perinatal Associates of New Mexico
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Subject is at least 18 years of age
- Subject in indicated for a routine Obstetrics/Gynecology ultrasound examination at the site.
- Subject is willing and capable of providing informed consent and participating in this study
Exclusion Criteria:
- A medical condition or co-morbidity that would be unduly affected by study participation, per investigator discretion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Experimental - Collaboration Live software
|
Collaboration Live is a non-diagnostic software solution intended for use with Philips (Philips Ultrasound, 22100 Bothell Everett Highway, Bothell, Washington 98021) EPIQ and Affiniti Series Ultrasound Systems (software version 5.0.2) that allows users to communicate (by text, voice, screen share, webcam video and remote takeover) from an ultrasound system or workstation to a remote destination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Clinically Acceptable Performance of Remote Control Functionality
Time Frame: Intra-procedural (1 day)
|
The system responds to the remote input as intended and without a delay interfering with the conduct of the exam.
Additionally, a clinically acceptable exam would result in no adverse events related to the control feature
|
Intra-procedural (1 day)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Technical Issues
Time Frame: Intra-procedural (1 day)
|
Number of subjects for which device deficiencies are reported
|
Intra-procedural (1 day)
|
|
Success Rates for Key Tasks in the Collaborative Exam
Time Frame: Intra-procedural (1 day)
|
Establishing the remote connection, establishing text chat, establishing voice call, establishing webcam feed, establishing screen share, establishing remote control
|
Intra-procedural (1 day)
|
|
Travel Reduction Attributable to Use of Collaboration Live
Time Frame: Intra-procedural (1 day)
|
Distance between the scanning facility and the investigator's location will be recorded (in miles).
|
Intra-procedural (1 day)
|
|
Ease of Use
Time Frame: Intra-procedural (1 day)
|
5-point (Likert) scale data will be reported by the investigator.(
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree)
|
Intra-procedural (1 day)
|
|
User Feedback Regarding Streaming, Image Quality and Overall Experience
Time Frame: Intra-procedural (1 day)
|
5-point (Likert) scale data will be reported by the investigator.
( 5 = Very good, 4 = Good, 3 = Acceptable, 2 = Poor, 1 = Very Poor)
|
Intra-procedural (1 day)
|
|
Patient Feedback Regarding Remote Consultation
Time Frame: 1 day
|
Tele-medicine Satisfaction Questionnaire
|
1 day
|
|
Impact of Remote Consultation on Reimbursement
Time Frame: 30 days
|
Submitted charges and reimbursement rates for remote patient consultation data will be recorded and compared to standard rates for in-person consultation
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 9, 2020
Primary Completion (Actual)
February 20, 2020
Study Completion (Actual)
February 20, 2020
Study Registration Dates
First Submitted
January 21, 2020
First Submitted That Met QC Criteria
January 24, 2020
First Posted (Actual)
January 28, 2020
Study Record Updates
Last Update Posted (Actual)
December 4, 2020
Last Update Submitted That Met QC Criteria
November 10, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- US-GIS-10649
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.